The economics of anticoagulation: what are the issues?
D000925:Anticoagulants / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D018890:Chemoprevention / Q000191:economics; D016903:Drug Monitoring / Q000191:economics; D017850:Economics, Pharmaceutical; D019983:Guideline Adherence; D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D011655:Pulmonary Embolism / Q000517:prevention & control; D020521:Stroke / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control; D020246:Venous Thrombosis / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin